Allergic Fungal Sinusitis Allergic Fungal Sinusitis William - - PowerPoint PPT Presentation

allergic fungal sinusitis allergic fungal sinusitis
SMART_READER_LITE
LIVE PREVIEW

Allergic Fungal Sinusitis Allergic Fungal Sinusitis William - - PowerPoint PPT Presentation

Allergic Fungal Sinusitis Allergic Fungal Sinusitis William Reisacher, MD FACS FAAOA William Reisacher, MD FACS FAAOA Assistant Professor Assistant Professor Weill Cornell Medical College Weill Cornell Medical College NewYork- -Presbyterian


slide-1
SLIDE 1

Allergic Fungal Sinusitis Allergic Fungal Sinusitis

William Reisacher, MD FACS FAAOA William Reisacher, MD FACS FAAOA Assistant Professor Assistant Professor Weill Cornell Medical College Weill Cornell Medical College NewYork NewYork-

  • Presbyterian Hospital

Presbyterian Hospital

slide-2
SLIDE 2

Background Background

  • Chronic

Chronic rhinosinusitis rhinosinusitis (CRS) is reported by (CRS) is reported by approximately 35 million Americans approximately 35 million Americans1

1

  • Direct cost of CRS in the USA is $4.3 billion

Direct cost of CRS in the USA is $4.3 billion annually annually2

2

  • 25

25-

  • 30% of CRS patients have nasal polyps (NP)

30% of CRS patients have nasal polyps (NP) 3

3

  • NP are found in 1

NP are found in 1-

  • 4% of the general population

4% of the general population4

4

  • Incidence slightly higher in males and elderly

Incidence slightly higher in males and elderly5

5

slide-3
SLIDE 3

Classification of NP Classification of NP6

6

CRS w/o NP

AFS

CRS w NP

CRS

slide-4
SLIDE 4

Background of AFS Background of AFS

  • Similarities with allergic

Similarities with allergic bronchopulmonary bronchopulmonary aspergillosis aspergillosis (ABPA) (ABPA)

  • Combination of

Combination of Gell Gell and Coombs types 1 and 3 and Coombs types 1 and 3 hypersensitivities hypersensitivities7

7

  • Bent and Kuhn diagnostic criteria (1994)

Bent and Kuhn diagnostic criteria (1994)8

8

– – Type I hypersensitivity Type I hypersensitivity – – Nasal polyps Nasal polyps – – Characteristic radiologic findings Characteristic radiologic findings – – Eosinophilic Eosinophilic mucus without fungal invasion into sinus mucus without fungal invasion into sinus tissue tissue – – Positive fungal stain of sinus contents removed at Positive fungal stain of sinus contents removed at surgery surgery

slide-5
SLIDE 5

Demographic Features of AFS Demographic Features of AFS

  • Young, atopic and

Young, atopic and immunocompetent immunocompetent

  • Mean age of presentation is 28.9

Mean age of presentation is 28.9

  • Lower socioeconomic status

Lower socioeconomic status

  • More common in southeastern United States

More common in southeastern United States7

7

  • 5

5-

  • 10% of all patient undergoing surgery for CRS

10% of all patient undergoing surgery for CRS7

7

  • Present in 51% of patients in Northern India with CRS

Present in 51% of patients in Northern India with CRS10

10

  • Wise et al.

Wise et al. – – African Americans with AFS presented with African Americans with AFS presented with mean age 11.7 years younger than Caucasians mean age 11.7 years younger than Caucasians11

11

  • Ghegan

Ghegan et al. et al. – – African American males were 15x more African American males were 15x more likely to have bone erosion than Caucasians and African likely to have bone erosion than Caucasians and African American females combined American females combined12

12

slide-6
SLIDE 6

Clinical Presentation of AFS Clinical Presentation of AFS

  • Headache

Headache

  • Unilateral nasal

Unilateral nasal congestion congestion

  • Diminished sense of

Diminished sense of smell and taste smell and taste

  • Postnasal drip

Postnasal drip

  • Refractory sinusitis

Refractory sinusitis

  • Proptosis

Proptosis, , telecanthus telecanthus

  • History of sinus

History of sinus surgery surgery

slide-7
SLIDE 7

Differential Diagnosis of AFS Differential Diagnosis of AFS

  • CRS with nasal

CRS with nasal polyposis polyposis

  • EMCRS

EMCRS

  • Invasive fungal sinusitis

Invasive fungal sinusitis

  • Mycetoma

Mycetoma ( (“ “Fungus ball Fungus ball” ”) )

  • Antrochoanal

Antrochoanal polyp polyp

  • Neoplasm

Neoplasm

– – Inverting Inverting papilloma papilloma – – Carcinoma Carcinoma – – Nasolacrimal Nasolacrimal duct cyst duct cyst – – Glioma Glioma, , dermoid dermoid lesions, lesions, encephaloceles encephaloceles

  • Inflammatory / Autoimmune

Inflammatory / Autoimmune

– – Wegener Wegener’ ’s s granulomatosis granulomatosis – – Sarcoidosis Sarcoidosis

  • Polypoid

Polypoid mucosal changes mucosal changes

slide-8
SLIDE 8

Radiologic Findings of AFS Radiologic Findings of AFS

CT scan T1 - MRI

slide-9
SLIDE 9

Gross and Gross and Histologic Histologic Appearance of Appearance of AFS AFS

  • Thick, dark, tenacious

Thick, dark, tenacious mucus mucus

  • Sheets of necrotic and

Sheets of necrotic and degranulating degranulating eosinophils eosinophils

  • Charcot

Charcot-

  • Leyden

Leyden crystals crystals

  • Scant fungal

Scant fungal hyphae hyphae

slide-10
SLIDE 10

Management of AFS Management of AFS

  • Medical management

Medical management

– – Anti Anti-

  • inflammatory medication

inflammatory medication – – Anti Anti-

  • fungal therapy

fungal therapy

  • Surgery

Surgery

  • Immunotherapy

Immunotherapy

slide-11
SLIDE 11

Medical Management Medical Management

  • Anti

Anti-

  • inflammatory

inflammatory

– – Systemic corticosteroids (pre Systemic corticosteroids (pre-

  • op/post
  • p/post-
  • op)
  • p)

– – Topical corticosteroids Topical corticosteroids – – Leukotriene Leukotriene receptor antagonists receptor antagonists – – Macrolide Macrolide antibiotics antibiotics

  • Anti

Anti-

  • fungal

fungal

– – Systemic Systemic – – Topical (Jen, Topical (Jen, Kacker Kacker, Huang et al. 2004) , Huang et al. 2004)13

13

slide-12
SLIDE 12

Surgical Management Surgical Management

  • Prior radical procedures replaced by complete, but

Prior radical procedures replaced by complete, but conservative endoscopic surgery. conservative endoscopic surgery.

  • Follow the polyps to the

Follow the polyps to the mucin mucin

  • Image

Image-

  • guidance if available

guidance if available

  • Don

Don’ ’t forget to send the t forget to send the mucin mucin for fungal staining for fungal staining

  • Post

Post-

  • operative debridement and irrigation
  • perative debridement and irrigation
  • Kupferberg

Kupferberg staging system staging system

– – Stage 0: NED Stage 0: NED – – Stage 1: Edematous mucosa/allergic Stage 1: Edematous mucosa/allergic mucin mucin – – Stage 2: Stage 2: Polypoid Polypoid mucosa/allergic mucosa/allergic mucin mucin – – Stage 3: Polyps and fungal debris Stage 3: Polyps and fungal debris

  • Need for revision surgery is about 30%

Need for revision surgery is about 30% 14

14

slide-13
SLIDE 13

Immunotherapy for AFS Immunotherapy for AFS

  • Mabry, et al. 1995

Mabry, et al. 1995 – – 9 AFS patients with no 9 AFS patients with no

  • controls. Less crust formation and post
  • controls. Less crust formation and post
  • perative
  • perative mucin

mucin and no adverse effects. and no adverse effects.15

15

  • Bassichis

Bassichis, et al. 2006 , et al. 200614

14

– – 60 patient with AFS 60 patient with AFS – – 24 patients, no IT. 36 patients, IT 24 patients, no IT. 36 patients, IT – – Average follow Average follow-

  • up was 48.5 months

up was 48.5 months – – Significant reduction of office visits Significant reduction of office visits – – Decrease in need for re Decrease in need for re-

  • operation from 33% to 11%
  • peration from 33% to 11%
slide-14
SLIDE 14

Dematiaceous Dematiaceous Fungi Fungi

“Darkly pigmented Darkly pigmented” ”

  • Present in 87% of

Present in 87% of culture positive culture positive-

  • cases

cases

  • f AFS
  • f AFS16

16

– – Alternaria Alternaria – – Bipolaris Bipolaris – – Curvularia Curvularia – – Helminthosporium Helminthosporium – – Fusarium Fusarium

  • 13% were

13% were aspergillus aspergillus

slide-15
SLIDE 15

Fungus and NP Fungus and NP

  • Ponikau

Ponikau et al. from Mayo Clinic suggested that NP may arise from et al. from Mayo Clinic suggested that NP may arise from immune hyper responsiveness to fungi that commonly colonize the immune hyper responsiveness to fungi that commonly colonize the nose of patients with CRS nose of patients with CRS17

17

  • Gosepath

Gosepath et al. demonstrated et al. demonstrated Alternaria Alternaria DNA in 100% of surgical DNA in 100% of surgical polyp specimens from CRS patients polyp specimens from CRS patients18

18

  • Sabirov

Sabirov et al. studied the role of local et al. studied the role of local IgE IgE specific for Alternaria specific for Alternaria19

19

– – CRS w NP (N= 21) vs. CRS w/o NP (N= 13) and healthy controls (N= 8) CRS w NP (N= 21) vs. CRS w/o NP (N= 13) and healthy controls (N= 8) – – Serum levels of Serum levels of Alternaria Alternaria-

  • specific

specific IgE IgE were no different between were no different between groups groups – – Alternaria Alternaria-

  • specific

specific IgE IgE in polyps was significantly higher than in the in polyps was significantly higher than in the nasal tissues of the other two groups nasal tissues of the other two groups

  • An association was present between

An association was present between alternaria alternaria-

  • specific

specific IgE IgE and and increased ECP and increased ECP and eosinophil eosinophil levels in patients with nasal polyps levels in patients with nasal polyps19

19

slide-16
SLIDE 16

Is AFS really Is AFS really “ “Allergic Allergic” ”? ?

  • Stewart and

Stewart and Hunsaker Hunsaker, 2002 , 200220

20

– – 13 AFS, 11 AFS 13 AFS, 11 AFS-

  • like, 27 non

like, 27 non-

  • AFS

AFS polypoid polypoid CRS CRS – – 9 mold RAST panel 9 mold RAST panel – – Elevated Elevated IgG IgG in all groups in all groups – – Elevated Elevated IgE IgE in AFS group to average of 5 molds vs. 0.1 in the in AFS group to average of 5 molds vs. 0.1 in the AFS AFS-

  • like group

like group

  • Wise, et al., 2008

Wise, et al., 200821

21

– – Sinus mucosa homogenates from AFS (11), Sinus mucosa homogenates from AFS (11), CRSsNP CRSsNP (8) and non (8) and non-

  • CRS patients (9)

CRS patients (9) – – ImmunoCAP ImmunoCAP for 14 common antigens for 14 common antigens – – AFS group had significantly higher levels of AFS group had significantly higher levels of IgE IgE for for Cladosporium Cladosporium, , Aspergillus Aspergillus, Timothy grass, red maple, cockroach, , Timothy grass, red maple, cockroach, ragweed and cocklebur ragweed and cocklebur

slide-17
SLIDE 17

Can non Can non-

  • allergic patients develop

allergic patients develop Allergic Fungal Sinusitis? Allergic Fungal Sinusitis?

  • Non

Non-

  • AFRS EMCRS

AFRS EMCRS22

22

– – Fungus not identified Fungus not identified histologically histologically – – Higher incidence of asthma, ASA sensitivity Higher incidence of asthma, ASA sensitivity – – Lower incidence of allergies Lower incidence of allergies – – Always bilateral Always bilateral

  • Collins, et al., 2004

Collins, et al., 200423

23

– – Comparison of AFRS with non Comparison of AFRS with non-

  • AFRS EMCRS (negative

AFRS EMCRS (negative for allergy and no fungus identified in the for allergy and no fungus identified in the mucin mucin) ) – – 17/24 AFRS had fungal specific 17/24 AFRS had fungal specific IgE IgE in in mucin mucin compared to 20% in non compared to 20% in non-

  • AFRS EMCRS

AFRS EMCRS – – Possibly a local Possibly a local IgE IgE-

  • mediated immune response

mediated immune response

slide-18
SLIDE 18

References References

1 1

Current Estimates from the National Health Interview Survey, 199 Current Estimates from the National Health Interview Survey, 1994. 4. National Center for Health Statistics. Vital and Health Statisti National Center for Health Statistics. Vital and Health Statistics 1995; cs 1995; Series 10. Series 10.

2 2

Murphy MP, Fishman P, Short SO, et al. Health care utilization a Murphy MP, Fishman P, Short SO, et al. Health care utilization and cost nd cost among adults with chronic among adults with chronic rhinosinusitis rhinosinusitis enrolled in a health maintenance enrolled in a health maintenance

  • rganization.
  • rganization. Otolaryngol

Otolaryngol Head Neck Head Neck Surg Surg 2002;127:367 2002;127:367-

  • 76.

76.

3 3

Bhattacharyya N. Clinical and symptom criteria for the Bhattacharyya N. Clinical and symptom criteria for the acurate acurate diagnosis diagnosis

  • f chronic
  • f chronic rhinosinusitis
  • rhinosinusitis. Laryngoscope 2006;116(Pt 2

. Laryngoscope 2006;116(Pt 2 Suppl Suppl 110):1 110):1-

  • 22.

22.

4 4

Van Van Zele Zele T, T, Gevaert Gevaert P, P, Holtappels Holtappels G, et al. Local immunoglobulin G, et al. Local immunoglobulin production in nasal production in nasal polyposis polyposis is modulated by is modulated by superantigens superantigens. . Clin Clin Exp All Exp All 2007;37:1840 2007;37:1840-

  • 7.

7.

5 5

Deal RT, Deal RT, Kountakis Kountakis SE. Significance of nasal polyps in chronic

  • SE. Significance of nasal polyps in chronic

rhinosinusitis rhinosinusitis: symptoms and surgical outcomes. Laryngoscope : symptoms and surgical outcomes. Laryngoscope 2004;114:1932 2004;114:1932-

  • 35.

35.

6 6

Meltzer EO, Meltzer EO, Hamilos Hamilos DL, Hadley JA, et al. DL, Hadley JA, et al. Rhinosinusitis Rhinosinusitis: establishing : establishing definitions for clinical research and patient care. J Allergy definitions for clinical research and patient care. J Allergy Clin Clin Immunol Immunol Suppl Suppl 2004;114:155 2004;114:155-

  • 212.

212.

slide-19
SLIDE 19

References References

7 7

Schubert MS. Allergic fungal sinusitis pathogenesis and Schubert MS. Allergic fungal sinusitis pathogenesis and management strategies. Drugs 2004;64:363 management strategies. Drugs 2004;64:363-

  • 374.

374.

8 8

Bent JP, Kuhn FA. Diagnosis of allergic fungal sinusitis. Bent JP, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Otolaryngol Head Neck Head Neck Surg Surg 1994;111:580 1994;111:580-

  • 588.

588.

9 9

Wise SK, Wise SK, Ghegan Ghegan MD, Gorham E, et al. Socioeconomic factors in MD, Gorham E, et al. Socioeconomic factors in the diagnosis of allergic fungal sinusitis. the diagnosis of allergic fungal sinusitis. Otolaryngol Otolaryngol Head Neck Head Neck Surg Surg 2008;138:38 2008;138:38-

  • 42.

42.

10 10

Saravanan Saravanan K, Panda NK, K, Panda NK, Chakrabarti Chakrabarti A. Allergic fungal sinusitis:

  • A. Allergic fungal sinusitis:

an attempt to resolve the diagnostic dilemma. Arch an attempt to resolve the diagnostic dilemma. Arch Otolaryngol Otolaryngol Head Neck Head Neck Surg Surg 2006;132(2):173 2006;132(2):173-

  • 178

178

11 11

Wise S, Wise S, Venkatraman Venkatraman G, Wise J, et al. Ethnic and gender G, Wise J, et al. Ethnic and gender differences in bone erosion in allergic fungal sinusitis. Am J differences in bone erosion in allergic fungal sinusitis. Am J Rhinol Rhinol 2004;18:397 2004;18:397-

  • 404.

404.

12 12

Ghegan Ghegan M, Lee, F, Schlosser R. Incidence of skull base and M, Lee, F, Schlosser R. Incidence of skull base and

  • rbital erosion in allergic fungal
  • rbital erosion in allergic fungal rhinosinusitis

rhinosinusitis (AFRS) and non (AFRS) and non-

  • AFRS.
  • AFRS. Otolaryngol

Otolaryngol Head Neck Head Neck Surg Surg 2006;134:592 2006;134:592-

  • 5.

5.

slide-20
SLIDE 20

References References

13 13

Jen A, Jen A, Kacker Kacker A, Huang C, et al. A, Huang C, et al. Fluconazole Fluconazole nasal spray in the nasal spray in the treatment of allergic fungal sinusitis: a pilot study. Ear Nose treatment of allergic fungal sinusitis: a pilot study. Ear Nose Throat J 2004;83:692 Throat J 2004;83:692-

  • 695.

695.

14 14

Bassichis Bassichis BA, BA, Marple Marple BF, Mabry RL. Use of immunotherapy in BF, Mabry RL. Use of immunotherapy in previously treated patients with allergic fungal sinusitis. previously treated patients with allergic fungal sinusitis. Otolaryngol Otolaryngol Head Neck Head Neck Surg Surg 2001;125(5):487 2001;125(5):487-

  • 490.

490.

15 15

Mabry RL, Manning SC, Mabry CS, et al. Immunotherapy in the Mabry RL, Manning SC, Mabry CS, et al. Immunotherapy in the treatment of allergic fungal sinusitis. treatment of allergic fungal sinusitis. Otolaryngol Otolaryngol Head Neck Head Neck Surg Surg 1997;116:31 1997;116:31-

  • 35.

35.

16 16

Manning SC, Schaefer SD, Close LG, et al. Culture Manning SC, Schaefer SD, Close LG, et al. Culture-

  • positive

positive allergic fungal sinusitis. Arch allergic fungal sinusitis. Arch Otolaryngol Otolaryngol Head Neck Head Neck Surg Surg 1991;117:174 1991;117:174-

  • 178.

178.

17 17

Ponikau Ponikau JU, JU, Sherris Sherris DA, Kern EB, et al. The diagnosis and DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo incidence of allergic fungal sinusitis. Mayo Clin Clin Proc 1999;74:844 Proc 1999;74:844-

  • 77.

77.

18 18

Gosepath Gosepath J, J, Brieger Brieger J, J, Vlachtsis Vlachtsis K, et al. Fungal DNA is present in K, et al. Fungal DNA is present in tissue specimens of patients with chronic tissue specimens of patients with chronic rhinosinusitis

  • rhinosinusitis. Am J

. Am J Rhinol Rhinol 2004;18:9 2004;18:9-

  • 13.

13.

slide-21
SLIDE 21

References References

19 19

Sabirov Sabirov A, Hamilton RG, Jacobs JB. Role of local immunoglobulin A, Hamilton RG, Jacobs JB. Role of local immunoglobulin E specific for E specific for alternaria alternaria alternata alternata in the pathogenesis of nasal in the pathogenesis of nasal polyposis

  • polyposis. Laryngoscope 2007;118:4

. Laryngoscope 2007;118:4-

  • 9.

9.

20 20

Stewart AE, Stewart AE, Hunsaker Hunsaker DH. Fungus

  • DH. Fungus-
  • specific

specific IgG IgG and and IgE IgE in Allergic in Allergic Fungal Fungal Rhinosinusitis Rhinosinusitis. . Otolaryngol Otolaryngol Head Neck Head Neck Surg Surg 2002;127:324 2002;127:324-

  • 332

332

21 21

Wise SK, Wise SK, Ahn Ahn CN, Lathers DM, et al. Antigen CN, Lathers DM, et al. Antigen-

  • specific

specific IgE IgE in sinus in sinus mucosa of allergic fungal mucosa of allergic fungal rhinosinusitis rhinosinusitis patients. Am J

  • patients. Am J Rhinol

Rhinol 2008;22(5):451 2008;22(5):451-

  • 456.

456.

22 22

Ferguson BJ. Ferguson BJ. Eosinophilic Eosinophilic mucin mucin rhinosinusitis rhinosinusitis: a distinct : a distinct clinicopathologic clinicopathologic entity. Laryngoscope 2000;110:799

  • entity. Laryngoscope 2000;110:799-
  • 813.

813.

23 23

Collins M, Nair S, Smith W, et al. Role of local immunoglobulin Collins M, Nair S, Smith W, et al. Role of local immunoglobulin E E production in the production in the pathophysiology pathophysiology of noninvasive fungal sinusitis.

  • f noninvasive fungal sinusitis.

Laryngoscope 2004;114:1242 Laryngoscope 2004;114:1242-

  • 1246.

1246.